CCELCryo-Cell International, Inc.

$25M

Q2 2017 Earnings

Healthcare Medical - Care Facilities

Income Statement

Revenue

$6M+8.0% YoY

Gross Profit

$5M74.5% margin

Operating Income

$1M19.1% margin

Net Income

$496,9408.0% margin

EPS (Diluted)

$0.06

QoQ Revenue Growth

+8.0%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$2M

Stock-Based Comp.

$393,662

Balance Sheet

Total Assets

$21M

Total Liabilities

$35M

Stockholders' Equity

-$14M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$6M	+8.0%
Gross Profit	$5M	$4M	+7.0%
Operating Income	$1M	$882,384	+35.1%
Net Income	$496,940	$637,132	-22.0%

Revenue Segments

Umbilical Cord Blood And Cord Tissue Stem Cell Service

$6M99%

Prepacyte-CB

$61,8551%

Geographic Segments

INDIA

$328,669100%

CCEL Q2 2017 Earnings — Cryo-Cell International, Inc. Revenue & Financial Results | Market Cap Arena